IPG Investment Advisors LLC Acquires New Shares in Synopsys, Inc. $SNPS

IPG Investment Advisors LLC bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,107 shares of the semiconductor company’s stock, valued at approximately $520,000.

Several other institutional investors also recently modified their holdings of the stock. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Synopsys in the 4th quarter valued at approximately $28,000. Oakworth Capital Inc. grew its holdings in Synopsys by 3,700.0% during the fourth quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock valued at $36,000 after purchasing an additional 74 shares during the period. KERR FINANCIAL PLANNING Corp bought a new stake in Synopsys in the third quarter valued at approximately $38,000. N.E.W. Advisory Services LLC increased its stake in Synopsys by 128.6% in the fourth quarter. N.E.W. Advisory Services LLC now owns 80 shares of the semiconductor company’s stock valued at $38,000 after purchasing an additional 45 shares in the last quarter. Finally, WealthCollab LLC raised its holdings in Synopsys by 110.8% in the third quarter. WealthCollab LLC now owns 78 shares of the semiconductor company’s stock worth $38,000 after purchasing an additional 41 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Synopsys Stock Down 8.6%

Synopsys stock opened at $480.64 on Friday. The company has a 50 day moving average of $458.59 and a 200-day moving average of $454.30. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73. The stock has a market capitalization of $92.07 billion, a PE ratio of 111.26, a price-to-earnings-growth ratio of 4.31 and a beta of 1.25.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.91%. The firm’s revenue was up 41.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities research analysts anticipate that Synopsys, Inc. will post 10.28 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. Rosenblatt Securities lifted their price target on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research report on Tuesday. Morgan Stanley raised their price objective on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday. Bank of America lifted their target price on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday. Stifel Nicolaus boosted their target price on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday. Finally, KeyCorp restated an “overweight” rating on shares of Synopsys in a report on Thursday. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $563.81.

Get Our Latest Report on SNPS

More Synopsys News

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys reported fiscal Q2 adjusted EPS of $3.35, beating estimates, on revenue of $2.28 billion, also ahead of expectations, with revenue up 41.9% year over year.
  • Positive Sentiment: The company lifted full-year FY2026 guidance, signaling continued demand for AI chip design software and stronger-than-expected momentum across the business.
  • Positive Sentiment: Synopsys reached a governance agreement with Elliott Investment Management and added Jesse Cohn to the board, which investors may view as a step toward better capital allocation and execution.
  • Positive Sentiment: Several analysts raised price targets after the earnings release, reflecting confidence in the company’s longer-term AI and semiconductor design opportunity.
  • Neutral Sentiment: Synopsys also showcased new AI-powered design flows and IP support for Samsung Foundry processes, reinforcing its position in advanced chip design.
  • Negative Sentiment: The stock is reacting negatively because investors may be worried that strong results are not enough to offset near-term business mix issues, including softness in chip IP and integration complexity tied to Ansys.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.